Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2013 | 09-2013 | 06-2013 | 05-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 7 | 90 | 638 | 638 |
| TOTAL | $41 | $154 | $225 | $672 | $672 |
| Non-Current Assets | |||||
| PPE Net | 176 | 205 | 178 | 181 | 181 |
| Other Non-Current Assets | 47 | 47 | 29 | 29 | 29 |
| TOTAL | $223 | $252 | $207 | $210 | $210 |
| Total Assets | $264 | $406 | $432 | $882 | $882 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 396 | 7 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 2,444 | 1,984 | 1,759 | 1,354 | 1,354 |
| Accrued Expenses | 626 | 462 | 371 | 343 | 343 |
| Other current liabilities | 4 | 30 | N/A | 0 | N/A |
| TOTAL | $5,206 | $3,253 | $2,933 | $2,414 | $2,414 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,855 | 3,517 | 3,327 | 3,198 | 3,198 |
| Other Non-Current Liabilities | 4,904 | 6,305 | 6,116 | 7,820 | 7,820 |
| TOTAL | $7,858 | $9,907 | $9,447 | $11,024 | $11,024 |
| Total Liabilities | $13,064 | $13,160 | $12,381 | $13,438 | $13,438 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 778 | 739 | 726 | N/A | 708 |
| Common Shares | 1 | 25 | 24 | 24 | 24 |
| Retained earnings | -70,637 | -68,943 | -67,484 | -67,669 | -67,669 |
| Other shareholders' equity | -166 | -172 | -177 | -177 | -177 |
| TOTAL | $-12,800 | $-12,754 | $-11,949 | $-12,556 | $-12,556 |
| Total Liabilities And Equity | $264 | $406 | $432 | $882 | $882 |